Clinical Trial Update: Effect of Rosuvastatin on Endothelial Function in Patients With Diabetes and Glaucoma [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluating rosuvastatin's effect on endothelial function in patients with diabetes and glaucoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Glaucoma

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Medical University of Vienna | Conditions: Glaucoma, Diabetes | Phase 4 | Status: WITHDRAWN